Four new additions to the Evitalin formulary: Expanding your longevity and optimization offering

The wellness and longevity market is consolidating around a simple truth: patients no longer want isolated treatments.

They want integrated protocols that address metabolic health, cellular function, regeneration, and aesthetic outcomes in a coordinated way. The clinics winning in this market are the ones with formularies deep enough to deliver on that expectation.

Evitalin and our pharmacy partner, PharmaLabs, have added four new products to the provider formulary: compounded testosterone cypionate, injectable glutathione, GHK-Cu topical creams (two formulations), and an at-home NAD+ test kit. Together, these give your practice more clinical range across weight management, cellular health, regenerative therapy, and longevity diagnostics.

Compounded testosterone cypionate: custom dosing for better patient outcomes

Commercially available testosterone cypionate works well for a segment of the TRT population.

But any provider running a practice that prescribes hormone replacement knows the limitations: fixed concentrations, IM-only administration in most branded products, and inactive ingredient profiles that cause reactions in a subset of patients.

Compounded testosterone cypionate through the Evitalin formulary solves for each of these. PharmaLabs can prepare custom concentrations, subcutaneous formulations, and combined-ester preparations (cypionate + propionate) that optimize the release curve for patients who struggle with the peaks and troughs of standard biweekly IM protocols.

For practices already offering TRT

This is a retention play. Patients who experience inconsistent symptom relief on commercial products are the ones most likely to shop around or discontinue. Custom compounding gives you a clinical tool to keep those patients progressing.

For practices looking to add TRT

Compounded testosterone cypionate is a lower barrier to entry than branded products, with the dosing flexibility to serve a wider patient population from day one.

Injectable glutathione: the antioxidant anchor for longevity protocols

Glutathione is the body’s master antioxidant, and endogenous production declines with age, chronic stress, and metabolic dysfunction.

Injectable glutathione delivers the molecule directly into systemic circulation, bypassing the absorption limitations of oral formulations and producing clinically meaningful effects on oxidative stress, detoxification pathways, and cellular repair.

For your practice, glutathione fits naturally into several protocols. It’s a strong adjunct for patients already on TRT or GLP-1 therapy who want broader metabolic and cellular support. It pairs well with NAD+ protocols as part of a cellular health stack. And it has standalone demand from aesthetically focused patients who respond to its effects on skin clarity and overall vitality.

Injectable administration (IM or subcutaneous) gives you dosing flexibility and the ability to integrate glutathione into combined-injection protocols alongside other peptides or nutrients your practice already offers.

GHK-Cu topical creams: regenerative therapy patients can take home

GHK-Cu (copper peptide) has a substantial evidence base for tissue repair, collagen synthesis, hair follicle signaling, and skin regeneration. The challenge has always been delivery.

Injectable GHK-Cu requires clinical administration and patient comfort with needles. Topical formulations put the same regenerative signaling peptide into a once-daily application patients can use at home.

Evitalin’s formulary now includes two GHK-Cu topical cream formulations:

• GHK-Cu 1% with estriol 0.3% and SH 0.5%: A lower-concentration GHK-Cu combined with estriol and sodium hyaluronate, well-suited for skin texture, fine lines, and hormonal skin changes in both male and female patients.
• GHK-Cu 4% with SH 0.5%: A higher-concentration formulation for patients pursuing more aggressive regenerative outcomes, including scalp application for hair density support and targeted skin rejuvenation.

Topical GHK-Cu gives your practice a take-home product that patients apply between visits, which drives adherence, extends the clinical relationship, and opens a product revenue line that doesn’t require injection-based follow-up. It also broadens your reach into aesthetically motivated patients who may not yet be candidates for injectable therapies.

NAD+ test kit: the diagnostic that opens the longevity conversation

NAD+ protocols (injectable, IV, and oral precursor) have moved from fringe to mainstream in wellness and longevity medicine.

What’s been missing at the provider level is a straightforward way to quantify patient NAD+ status before and during treatment. Without baseline data, providers are prescribing blind and patients are dosing on faith.

Patients order the kit through your clinic, collect a sample at home, and return results that quantify their cellular NAD+ levels. From there, you have an objective starting point for recommending a protocol, tracking response, and justifying continued therapy.

For your practice, this test kit gives you a low-friction entry point for patients curious about longevity medicine but not yet committed to a treatment protocol.

Abnormal results become a clinical conversation. Normal results become a baseline for future monitoring. Either way, the patient is now in your practice.

The clinical differentiation that platforms can’t replicate

A deeper formulary only matters if your clinic can apply it with judgment.

Here’s what separates your practice from DTC platforms offering the same molecules:

• Integrated protocols: You build stacks that address metabolic, hormonal, regenerative, and cellular health as a coordinated whole. Platforms sell products in isolation.
• Diagnostic-led prescribing: You use tests like the NAD+ kit to ground treatment decisions in data. Platforms rely on symptom questionnaires.
• Titration and combination expertise: You adjust dosing across multiple compounds based on labs, symptoms, and how protocols interact. Platforms follow static dosing regardless of what else the patient is taking.
• Continuity of care: When a patient’s protocol needs adjustment, they see you. Not a rotating roster of telehealth providers.

To add the above medications and tools to your formulary, log into your Evitalin portal or contact your account manager today.